AmerisourceBergen Corp. (NYSE:ABC) EVP Sells $311,256.06 in Stock

AmerisourceBergen Corp. (NYSE:ABC) EVP Gina Clark sold 3,098 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $100.47, for a total transaction of $311,256.06. Following the completion of the sale, the executive vice president now directly owns 16,667 shares in the company, valued at $1,674,533.49. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Gina Clark also recently made the following trade(s):

  • On Wednesday, May 27th, Gina Clark sold 3,098 shares of AmerisourceBergen stock. The stock was sold at an average price of $90.96, for a total transaction of $281,794.08.
  • On Monday, April 27th, Gina Clark sold 3,099 shares of AmerisourceBergen stock. The stock was sold at an average price of $89.60, for a total transaction of $277,670.40.

ABC traded up $0.20 during midday trading on Tuesday, hitting $99.20. 162,485 shares of the company traded hands, compared to its average volume of 1,394,518. The company has a quick ratio of 0.63, a current ratio of 0.97 and a debt-to-equity ratio of 0.98. The firm has a market capitalization of $20.08 billion, a PE ratio of 12.99, a price-to-earnings-growth ratio of 1.87 and a beta of 0.62. The company’s 50-day moving average is $95.26 and its 200 day moving average is $89.44. AmerisourceBergen Corp. has a 52 week low of $72.06 and a 52 week high of $103.37.

AmerisourceBergen (NYSE:ABC) last posted its earnings results on Thursday, May 7th. The company reported $2.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.13. The business had revenue of $47.42 billion for the quarter, compared to analysts’ expectations of $45.90 billion. AmerisourceBergen had a net margin of 0.85% and a return on equity of 48.85%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.11 EPS. On average, sell-side analysts predict that AmerisourceBergen Corp. will post 7.45 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the business. WASHINGTON TRUST Co bought a new position in shares of AmerisourceBergen in the 1st quarter worth approximately $25,000. Virtus ETF Advisers LLC bought a new position in shares of AmerisourceBergen in the 4th quarter worth approximately $26,000. Harbor Investment Advisory LLC lifted its stake in shares of AmerisourceBergen by 910.0% in the 1st quarter. Harbor Investment Advisory LLC now owns 303 shares of the company’s stock worth $27,000 after purchasing an additional 273 shares during the period. OmniStar Financial Group Inc. bought a new position in shares of AmerisourceBergen in the 1st quarter worth approximately $29,000. Finally, Truvestments Capital LLC bought a new position in shares of AmerisourceBergen in the 1st quarter worth approximately $31,000. Institutional investors and hedge funds own 64.25% of the company’s stock.

A number of research firms have recently weighed in on ABC. UBS Group reduced their target price on shares of AmerisourceBergen from $108.00 to $99.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. JPMorgan Chase & Co. upgraded shares of AmerisourceBergen from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $93.00 to $106.00 in a research note on Wednesday, April 1st. Credit Suisse Group began coverage on shares of AmerisourceBergen in a research note on Wednesday, April 22nd. They issued a “buy” rating and a $105.00 price target on the stock. Zacks Investment Research cut shares of AmerisourceBergen from a “buy” rating to a “hold” rating and set a $93.00 price target on the stock. in a research note on Wednesday, April 1st. Finally, Deutsche Bank upped their price target on shares of AmerisourceBergen from $93.00 to $98.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $103.89.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Featured Story: What is a trade deficit?

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.